Journal Article

FZJ-2021-05962

http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png Psilocybin targets a common molecular mechanism for cognitive impairment and increased craving in alcoholism

Meinhardt, M. W. (Corresponding author) ; Pfarr, S. ; Fouquet, G. ; Rohleder, C. ; Meinhardt, M. L. ; Barroso-Flores, J. ; Hoffmann, R. ; Jeanblanc, J. ; Paul, E. ; Wagner, K. ; Hansson, A. C. ; Köhr, G. ; Meier, N. ; von Bohlen und Halbach, O. ; Bell, R. L. ; Endepols, H.FZJ* ; Neumaier, B.FZJ* ; Schönig, K. ; Bartsch, D. ; Naassila, M. ; Spanagel, R. (Corresponding author) ; Sommer, W. H. (Corresponding author)

2021
Assoc. Washington, DC [u.a.]

This record in other databases:      

Please use a persistent id in citations: http://hdl.handle.net/2128/30110  doi:10.1126/sciadv.abh2399

Abstract: Alcohol-dependent patients commonly show impairments in executive functions that facilitate craving and can lead to relapse. However, the molecular mechanisms leading to executive dysfunction in alcoholism are poorly understood, and new effective pharmacological treatments are desired. Here, using a bidirectional neuromodulation approach, we demonstrate a causal link between reduced prefrontal mGluR2 function and both impaired executive control and alcohol craving. A neuron-specific prefrontal mGluR2 knockdown in rats generated a phenotype of reduced cognitive flexibility and excessive alcohol seeking. Conversely, virally restoring prefrontal mGluR2 levels in alcohol-dependent rats rescued these pathological behaviors. In the search for a pharmacological intervention with high translational potential, psilocybin was capable of restoring mGluR2 expression and reducing relapse behavior. Last, we propose a FDG-PET biomarker strategy to identify mGluR2 treatment-responsive individuals. In conclusion, we identified a common molecular pathological mechanism for both executive dysfunction and alcohol craving and provided a personalized mGluR2 mechanism-based intervention strategy for medication development for alcoholism.

---

Contributing Institute(s):

1. Nuklearchemie (INM-5)

Research Program(s):

1. 5253 - Neuroimaging (POF4-525) (POF4-525)

Appears in the scientific report 2021

---

Database coverage:
; ; ; ; Article Processing Charges ; Clarivate Analytics Master Journal List ; Current Contents - Physical, Chemical and Earth Sciences ; DOAJ Seal ; Ebsco Academic Search ; Essential Science Indicators ; Fees ; IF >= 10 ; JCR ; PubMed Central ; SCOPUS ; Science Citation Index Expanded ; Web of Science Core Collection ; Zoological Record

---